Actinium Pharmaceuticals reported 0 in Gross Profit on Sales for its fiscal quarter ending in March of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Actinium Pharmaceuticals 0 0 Mar/2025
Amgen USD 6.48B 307M Sep/2025
Bioline Rx USD 343K 111K Sep/2025
Capricor Therapeutics 0 11.13M Mar/2025
Pfizer USD 3.54B 7.61B Sep/2025